NYSEMKT: TOVX
Theriva Biologics Inc Stock Ownership - Who owns Theriva Biologics?

Insider buying vs selling

Have Theriva Biologics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when TOVX insiders and whales buy or sell their stock.

TOVX Shareholders

What type of owners hold Theriva Biologics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Steven A. Shallcross8.98%250,000$353.50kInsider
Ubs Group Ag0.59%16,406$23.20kInstitution
Citigroup Inc0.28%7,756$10.97kInstitution
Blackrock Inc0.27%7,568$10.70kInstitution
Tower Research Capital LLC Trc0.05%1,391$1.97kInstitution
Osaic Holdings Inc0.05%1,294$1.83kInstitution
Bank Of America Corp0.00%20$28.28Institution
Iron Horse Wealth Management LLC0.00%14$19.80Institution
Ifp Advisors Inc0.00%11$15.55Institution
Sbi Securities Co Ltd0.00%10$14.14Institution

1 of 2

TOVX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TOVX1.24%8.98%
CDT12.56%87.44%Net SellingNet Buying
GLTO2.08%97.92%Net Selling
THAR3.64%96.36%Net Buying
CELZ1.71%2.02%Net SellingNet Selling

Theriva Biologics Stock Ownership FAQ

Who owns Theriva Biologics?

Theriva Biologics (NYSEMKT: TOVX) is owned by 1.24% institutional shareholders, 8.98% Theriva Biologics insiders, and 89.78% retail investors. Steven A. Shallcross is the largest individual Theriva Biologics shareholder, owning 250,000.00 shares representing 8.98% of the company. Steven A. Shallcross's Theriva Biologics shares are currently valued at $337.50k.

If you're new to stock investing, here's how to buy Theriva Biologics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.